Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.52 - $0.91 $5,950 - $10,414
11,444 New
11,444 $6,000
Q4 2022

Feb 14, 2023

SELL
$0.97 - $45.0 $123,055 - $5.71 Million
-126,861 Reduced 89.97%
14,136 $16,000
Q3 2022

Nov 14, 2022

BUY
$1.22 - $40.8 $58,562 - $1.96 Million
48,002 Added 51.62%
140,997 $183,000
Q2 2022

Aug 15, 2022

SELL
$1.15 - $3.34 $11,602 - $33,697
-10,089 Reduced 9.79%
92,995 $149,000
Q1 2022

May 16, 2022

BUY
$2.96 - $7.76 $305,128 - $799,931
103,084 New
103,084 $317,000
Q4 2021

Feb 14, 2022

SELL
$7.4 - $11.66 $430,361 - $678,110
-58,157 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$9.18 - $14.15 $192,311 - $296,428
20,949 Added 56.3%
58,157 $671,000
Q2 2021

Aug 16, 2021

BUY
$8.07 - $12.52 $210,602 - $326,734
26,097 Added 234.88%
37,208 $466,000
Q1 2021

May 17, 2021

SELL
$8.57 - $15.79 $19,231 - $35,432
-2,244 Reduced 16.8%
11,111 $115,000
Q4 2020

Feb 16, 2021

BUY
$5.98 - $12.47 $46,972 - $97,951
7,855 Added 142.82%
13,355 $111,000
Q3 2020

Nov 16, 2020

SELL
$4.65 - $8.73 $232,221 - $435,976
-49,940 Reduced 90.08%
5,500 $34,000
Q2 2020

Aug 14, 2020

BUY
$4.66 - $8.7 $170,691 - $318,672
36,629 Added 194.72%
55,440 $462,000
Q1 2020

May 15, 2020

BUY
$5.05 - $15.01 $94,995 - $282,353
18,811 New
18,811 $113,000
Q3 2019

Nov 14, 2019

SELL
$8.03 - $14.82 $88,538 - $163,405
-11,026 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$11.88 - $16.94 $130,988 - $186,780
11,026 New
11,026 $146,000

Others Institutions Holding DTIL

About PRECISION BIOSCIENCES INC


  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $584M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.